Search
for
Sort by
Research 301–330 of 1000+
- Excellent response to tofacitinib treatment in a patient with alopecia universalis
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Under Development JAK Inhibitors for Dermatologic Diseases
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Rethinking the classification of alopecia areata
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Alopecia areata – Current understanding and management
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Unraveling the secret life of the hair follicle: from fungi to innovative hair loss therapies
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Ruxolitinib found to cause eyelash growth: a case report
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Alopecia areata following COVID-19 vaccine: a systematic review
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Folliculitis decalvans responsive to tofacitinib: A case series
- Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- What is behind the ‘swarm of bees’ in alopecia areata
- New Treatments for Hair Loss
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Mechanisms of autophagy and their implications in dermatological disorders
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Baricitinib for the Treatment of Alopecia Areata